New insider Braeden Lichti claimed ownership of 1,906,414 shares (SEC Form 3) (Amendment)
$ELAB
Biotechnology: Pharmaceutical Preparations
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 12/28/2023 |
3. Issuer Name and Ticker or Trading Symbol
Elevai Labs Inc. [ ELAB ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) 02/01/2024 |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 1,906,414 | I | By BWL Investments Ltd.(1) |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Option | 02/09/2021 | 02/08/2031 | Common Stock | 200,000(2) | $0.6 | D | |
| Warrant | 04/28/2022 | 05/25/2027 | Common Stock | 61,551(3) | $2.012 | I | By BWL Investments Ltd(3) |
| Explanation of Responses: |
| 1. This amendment is being filed to correct the number of shares of common stock of the Issuer held by Braeden Lichti indirectly through BWL Investments Ltd, which was incorrectly reported on Mr. Lichti's Form 3 filed on February 1, 2024. As of December 28, 2023, BWL Investments Ltd., a company owned and controlled by Braeden Lichti, owned 1,906,414 shares of common stock of the Issuer. |
| 2. As of December 28, 2023, Mr. Lichti owned a stock option to purchase 200,000 shares of common stock of the Issuer This amendment is being filed to include this stock option, which was inadvertently omitted from Mr. Lichti's Form 3 filed on February 1, 2024. |
| 3. As of December 28, 2023, BWL Investments Ltd., a company owned and controlled by Mr. Lichti, held a warrant to purchase 61,551 shares of common stock of the Issuer. This amendment is being filed to include this warrant beneficially owned indirectly by Braeden Lichti which was inadvertently omitted from Mr. Lichti's Form 3 filed on February 1, 2024. |
| /s/ Braeden Lichti | 02/16/2024 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||